The Indian pharmaceutical sector experienced a significant downturn, with several major stocks witnessing a sharp decline of over 10%, as market participants reacted to escalating concerns stemming from potential tariff
The Indian pharmaceutical sector experienced a significant downturn, with several major stocks witnessing a sharp decline of over 10%, as market participants reacted to escalating concerns stemming from potential tariff